BioInvent International AB (OMX:BINV)

European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BINV

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BINV

  • Market CapSEK0.000m
  • SymbolOMX:BINV
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINSE0015244520

Company Profile

BioInvent International AB is a biopharmaceutical company. It develops antibody-based drugs in the field of cancer, focusing on hematological cancers. The company's technology platforms consist of the n-CoDeR antibody library and the unique F.I.R.S.T. development tool. Its product includes; BI-505, BI-1206, n-CoDeR, F.I.R.S.T. and TB-403. Geographically, it derives maximum revenue from the United States followed by Sweden.BioInvent International AB develops immuno-oncological antibody drugs. The Company's projects that have advanced the farthest are aimed at haematological cancer.

Latest BINV news

Currently there for this company. Visit our news hub for other news .